Table 3.
Associations with self-reporting MDD among participants with a recorded history of MDD.
Self-reported history of depression among EHR-MDD |
|||
---|---|---|---|
Participant characteristics | Positive (n = 6689) | Negative (n = 2720) | aOR (95 % CI)a |
Sociodemographic characteristics,n(row %) | |||
Age at enrollment | |||
18–44 | 1643 (78.9 %) | 439 (21.1 %) | Reference |
45–54 | 1392 (75 %) | 465 (25 %) | 0.82 (0.71,0.95) |
55–64 | 1742 (73.7 %) | 621 (26.3 %) | 0.79 (0.69,0.91) |
65 + | 1912 (61.5 %) | 1195 (38.5 %) | 0.47 (0.41,0.53) |
Gender Identity | |||
Female | 5073 (73.4 %) | 1839 (26.6 %) | Reference |
Male | 1616 (64.7 %) | 881 (35.3 %) | 0.71 (0.65,0.79) |
Race | |||
White | 6188 (71.5 %) | 2471 (28.5 %) | Reference |
Black or African American | 44 (67.7 %) | 21 (32.3 %) | 0.67 (0.39,1.16) |
Asian | 30 (57.7 %) | 22 (42.3 %) | 0.45 (0.26,0.81) |
American Indian, Alaska Native, Native Hawaiian, or Pacific Islander |
11 (64.7 %) | 6 (35.3 %) | 0.66 (0.24,1.96) |
Multi-racial | 356 (68.7 %) | 162 (31.3 %) | 0.95 (0.78,1.16) |
Other | 26 (57.8 %) | 19 (42.2 %) | 0.51 (0.28,0.94) |
Ethnicity | |||
Non-Hispanic | 6539 (71.3 %) | 2635 (28.7 %) | Reference |
Hispanic | 97 (68.3 %) | 45 (31.7 %) | 0.71 (0.50,1.04) |
Education | |||
High school or less | 1056 (66.2 %) | 540 (33.8 %) | 0.93 (0.80,1.07) |
Some college | 2622 (72.8 %) | 981 (27.2 %) | 1.09 (0.96,1.23) |
College graduate | 1543 (71.6 %) | 612 (28.4 %) | Reference |
Postgraduate | 1358 (72.2 %) | 523 (27.8 %) | 1.17 (1.02,1.35) |
Marital status | |||
Married or marriage-like | 4579 (69.9 %) | 1972 (30.1 %) | Reference |
Separated/Divorced | 887 (77.9 %) | 252 (22.1 %) | 1.44 (1.24,1.68) |
Widowed | 378 (61.3 %) | 239 (38.7 %) | 0.85 (0.71,1.02) |
Never married | 677 (78.3 %) | 188 (21.7 %) | 1.23 (1.03,1.47) |
Unemployed under age 65 | |||
No | 5021 (69.0 %) | 2251 (31.0 %) | Reference |
Yes | 1608 (78.4 %) | 442 (21.6 %) | 1.22 (1.07,1.40) |
Health-related characteristics,n(row %) | |||
Smoking status | |||
Never | 3515 (70.8 %) | 1448 (29.2 %) | Reference |
Former | 2468 (70.8 %) | 1017 (29.2 %) | 1.13 (1.02,1.24) |
Current | 596 (75.5 %) | 193 (24.5 %) | 1.11 (0.93,1.32) |
Alcohol use | |||
Never | 1756 (70.4 %) | 737 (29.6 %) | Reference |
Once a month or less | 1664 (74.4 %) | 574 (25.6 %) | 1.10 (0.96,1.25) |
2–4 a month | 1477 (71.4 %) | 593 (28.6 %) | 0.94 (0.83,1.08) |
2–3 a week | 822 (68.2 %) | 383 (31.8 %) | 0.84 (0.72,0.98) |
4–5 a week | 460 (69.3 %) | 204 (30.7 %) | 0.99 (0.82,1.20) |
6 or more a week | 472 (70.3 %) | 199 (29.7 %) | 1.09 (0.90,1.32) |
Body mass index | |||
Underweight | 71 (74.7 %) | 24 (25.3 %) | 1.13 (0.71,1.86) |
Normal | 1629 (70.1 %) | 694 (29.9 %) | Reference |
Overweight | 1952 (68.8 %) | 886 (31.2 %) | 1.07 (0.95,1.21) |
Obese | 2663 (73.3 %) | 972 (26.7 %) | 1.28 (1.13,1.44) |
Charlson index | |||
0 | 2130 (73.2 %) | 778 (26.8 %) | Reference |
1–2 | 1917 (73.1 %) | 706 (26.9 %) | 1.17 (1.04,1.33) |
3–4 | 688 (67.9 %) | 325 (32.1 %) | 1.10 (0.93,1.30) |
5 or more | 563 (65.8 %) | 292 (34.2 %) | 1.01 (0.85,1.21) |
Anxiety disordersb | |||
No | 4058 (68.4 %) | 1877 (31.6 %) | Reference |
Yes | 2631 (75.7 %) | 843 (24.3 %) | 1.39 (1.26,1.53) |
Attention-deficit/hyperactivity disorderb | |||
No | 6446 (70.7 %) | 2677 (29.3 %) | Reference |
Yes | 243 (85.0 %) | 43 (15.0 %) | 1.93 (1.40,2.72) |
Substance use disordersb | |||
No | 5390 (70.7 %) | 2233 (29.3 %) | Reference |
Yes | 1299 (72.7 %) | 487 (27.3 %) | 1.07 (0.95,1.20) |
Clinical characteristics,n(row %) | |||
MDD Screen at enrollmentc | |||
Negative | 5311 (68.2 %) | 2478 (31.8 %) | Reference |
Positive | 1315 (87.3 %) | 191 (12.7 %) | 2.98 (2.54,3.51) |
Total unique antidepressant classes | |||
0 | 385 (41.0 %) | 555 (59.0 %) | Reference |
1 | 2632 (67.8 %) | 1250 (32.2 %) | 3.27 (2.81,3.82) |
2 | 2073 (77.1 %) | 614 (22.9 %) | 5.45 (4.62,6.43) |
3 or more | 1599 (84.2 %) | 301 (15.8 %) | 8.98 (7.44,10.85) |
Recency of last MDD episode | |||
< 90days | 2051 (82.6 %) | 432 (17.4 %) | Reference |
90days-< 1 yr | 1352 (78.8 %) | 363 (21.2 %) | 0.82 (0.70,0.96) |
1yr-< 3 yrs | 1644 (71.8 %) | 645 (28.2 %) | 0.58 (0.50,0.67) |
3yrs-< 5 yrs | 712 (64.4 %) | 393 (35.6 %) | 0.41 (0.35,0.48) |
5 yrs+ | 930 (51.2 %) | 887 (48.8 %) | 0.23 (0.20,0.26) |
Social and emotional well-being characteristics,n(row %) | |||
Overall mental well-being | |||
0–5 (low) | 1208 (84.9 %) | 215 (15.1 %) | 2.83 (2.42,3.33) |
6–7 (low normal) | 1705 (78.0 %) | 480 (22.0 %) | 1.82 (1.62,2.05) |
8 + (high normal) | 3763 (65.1 %) | 2017 (34.9 %) | Reference |
Overall emotional well-being | |||
0–5 (low) | 1808 (85.4 %) | 310 (14.6 %) | 3.39 (2.96,3.89) |
6–7 (low normal) | 1965 (76.2 %) | 615 (23.8 %) | 1.87 (1.67,2.08) |
8 + (high normal) | 2906 (61.9 %) | 1787 (38.1 %) | Reference |
Emotional health | |||
Excellent | 236 (47.8 %) | 258 (52.2 %) | Reference |
Very good | 1537 (61.8 %) | 949 (38.2 %) | 1.75 (1.44,2.13) |
Good | 2121 (69.3 %) | 939 (30.7 %) | 2.42 (1.99,2.94) |
Fair | 1919 (81.5 %) | 435 (18.5 %) | 4.58 (3.72,5.65) |
Poor | 809 (88.7 %) | 103 (11.3 %) | 7.59 (5.78,10.04) |
EHR Density,n(row %) | |||
EHR length (years) | |||
Q1: ≤ 2.62 | 966 (80.6 %) | 232 (19.4 %) | 1.86 (1.58,2.19) |
Q2: 2.63–8.17 | 1664 (71.0 %) | 680 (29.0 %) | 1.17 (1.04,1.31) |
Q3: 8.18–13.3 | 1833 (70.4 %) | 772 (29.6 %) | 1.11 (0.99,1.24) |
Q4: 13.4 + | 2226 (68.2 %) | 1036 (31.8 %) | Reference |
Diagnostic frequency (mean visits per year) | |||
Q1: < 2.72 | 624 (72.9 %) | 232 (27.1 %) | 1.04 (0.87,1.23) |
Q2: 2.72–5.82 | 1331 (68.6 %) | 610 (31.4 %) | 0.85 (0.75,0.97) |
Q3: 5.83–11.6 | 2141 (69.9 %) | 921 (30.1 %) | 0.89 (0.80,1.00) |
Q4: 11.7 + | 2593 (73.0 %) | 957 (27.0 %) | Reference |
MDD Polygenic Risk Score | |||
Continuous PRS (Linear) | |||
Participants, n (missing) | 5303 (1386) | 2171 (549) | 1.10 (1.05,1.16) |
PRS-MDD, median (IQR) | 0.2 (−0.5:0.9) | 0.1 (−0.6:0.8) |
aOR, adjusted odds ratio; CI, confidence interval; EHR, electronic health record; IQR, interquartile range; MDD, major depressive disorder; PQ, participant questionnaire; Q, quartile.
Odds ratios and 95 % confidence intervals for participants with EHR-MDD, comparing participants that self-reported MDD history vs. those that did not. Adjusted for age, gender, and EHR length. Tests exploring age, gender and length of EHR were unadjusted for said variable.
Comorbidities were defined as the presence of at least one diagnostic code in a participants EHR.
Screened using a modified version of the Patient Health Questoinnaire-2 in the participant questionnaire.